{
    "nct_id": "NCT04066725",
    "official_title": "A Phase II Placebo-controlled Intervention Trial of Oral Aspirin (ASA) as a UV Protectant in Vivo",
    "inclusion_criteria": "* Must have at least 2 nevi (each >5 mm diameter) not clinically suspicious for melanoma that can be biopsied.\n* Must be older than age 18.\n* Must be able to receive informed consent and sign an approved consent form that conforms to federal and institutional guidelines.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* The patient cannot speak / understand English or Spanish.\n* The patient is pregnant or breastfeeding.\n* The patient is a prisoner, critically or mentally ill, or otherwise incapacitated or considered vulnerable.\n* The patient has history of allergic reaction to ASA.\n* The patient has history of severe asthma.\n* The patient has been taking ASA or any NSAID in the past 2 weeks.\n* The patient has been taking a blood thinner in the past 2 weeks.\n* The patient has history of bleeding disorder.\n* The patient has history of peptic ulcer disease.\n* The patient has had recent intense UV exposure in the past month.",
    "miscellaneous_criteria": ""
}